financetom
Business
financetom
/
Business
/
--Intel Says it Currently Does 'Not Have Any Plans' to Divest a Majority Stake in Mobileye
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Intel Says it Currently Does 'Not Have Any Plans' to Divest a Majority Stake in Mobileye
Sep 22, 2024 5:00 PM

07:26 AM EDT, 09/19/2024 (MT Newswires) --

Price: 21.19, Change: +0.42, Percent Change: +2.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Monroe Capital Supports Respida Capital’s Acquisition of ENTOUCH
Monroe Capital Supports Respida Capital’s Acquisition of ENTOUCH
Nov 10, 2025
CHICAGO--(BUSINESS WIRE)-- Monroe Capital LLC (“Monroe”) announced it led the growth capital investment to support the acquisition of ENTOUCH by Respida Capital. Founded in Dallas, Texas in 2008, ENTOUCH provides energy management as a service and smart building technology. The company’s cloud-based software delivers sustainable solutions that reduce energy usage, drive profitably, and simplify facility management for multisite operators. “We...
E.l.f. Beauty Says e.l.f.iverse Launches at ULTA Beauty in Mexico; Shares Up Pre-Bell
E.l.f. Beauty Says e.l.f.iverse Launches at ULTA Beauty in Mexico; Shares Up Pre-Bell
Nov 10, 2025
05:52 AM EST, 11/10/2025 (MT Newswires) -- E.l.f. Beauty (ELF) said Monday it has officially launched its e.l.f.iverse at ULTA Beauty ( ULTA ) in Mexico. The company said e.l.f. Cosmetics and e.l.f. SKIN products will now be available in all ULTA Beauty ( ULTA ) stores across the country as well as on the retailer's e-commerce platform. E.l.f. Beauty...
Merck's Phase 3 Trial of Enlicitide Decanoate in Heterozygous Familial Hypercholesterolemia Achieves Primary Endpoint
Merck's Phase 3 Trial of Enlicitide Decanoate in Heterozygous Familial Hypercholesterolemia Achieves Primary Endpoint
Nov 10, 2025
05:54 AM EST, 11/10/2025 (MT Newswires) -- Merck ( MRK ) said Sunday that a phase 3 study of its elicitide decanoate product candidate achieved its primary endpoint, demonstrating statistically significant reduction in low-density lipoprotein cholesterol, or LDL-C, in adult patients with heterozygous familial hypercholesterolemia. The company said enlicitide led to a clinically meaningful LDL-C reduction of 59.4% compared with...
Cargojet Renews Normal Course Issuer Bid for Voting Shares
Cargojet Renews Normal Course Issuer Bid for Voting Shares
Nov 10, 2025
05:55 AM EST, 11/10/2025 (MT Newswires) -- Cargojet ( CGJTF ) , which rose 2.5% on Friday, later that day said it has received approval from the Toronto Stock Exchange to renew its normal course issuer bid for common voting shares and variable voting shares. The NCIB is scheduled to run from Nov. 11, 2025, to Nov. 10, 2026. Purchases...
Copyright 2023-2026 - www.financetom.com All Rights Reserved